ESGO/LinkedIn
Jul 22, 2025, 09:34
Why was the TRUST trial conducted? – European Society of Gynaecological Oncology
European Society of Gynaecological Oncology (ESGO) shared the post on LinkedIn:
“Why was the TRUST trial conducted? Sven Mahner on the rationale behind the study:
“A trial built on strict quality criteria to achieve high resection rates in operable cases.”
Watch the full conversation with Sven Mahner and Christina Fotopoulou Fotopoulou on ESGO eAcademy.
More on the TRUST trial.”
More posts featuring European Society of Gynaecological Oncology.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 13, 2025, 20:15
Aug 13, 2025, 19:46
Aug 13, 2025, 19:37
Aug 13, 2025, 19:21
Aug 13, 2025, 19:12
Aug 13, 2025, 15:55
Aug 13, 2025, 15:48
Aug 13, 2025, 15:36